Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer

Comment

John K Chan et al. N Engl J Med. 2016.

. 2016 Jun 30;374(26):2603-4.

doi: 10.1056/NEJMc1603849.

No abstract available

Comment on

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, Huh WK, O'Malley DM, Boente MP, Michael H, Monk BJ. Chan JK, et al. N Engl J Med. 2016 Feb 25;374(8):738-48. doi: 10.1056/NEJMoa1505067. N Engl J Med. 2016. PMID: 26933849 Free PMC article. Clinical Trial.
Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer.
Narod SA. Narod SA. N Engl J Med. 2016 Jun 30;374(26):2602. doi: 10.1056/NEJMc1603849. N Engl J Med. 2016. PMID: 27355550 No abstract available.
Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer.
Pimenta L, Dornelas M, Cezana L. Pimenta L, et al. N Engl J Med. 2016 Jun 30;374(26):2602-3. doi: 10.1056/NEJMc1603849. N Engl J Med. 2016. PMID: 27355551 No abstract available.